7 buildings in Fobei park to be delivered this year

guangdong.chinadaily.com.cn/fs-hitech Updated: August 12,2022

Recently, Guangdong Medical Valley·Yundonghai Life Science Park, which is located in the Fobei Zhanxin Industrial Park of the Foshan National Hi-tech Industrial Development Zone, held the roof-topping ceremony of the first building.

By the end of August, 6 buildings in the project will be capped. It is expected that 7 buildings will be delivered by the end of 2022, with a further 22 to be delivered by June 2023.


The first building of the Guangdong Medical Valley Yundonghai Life Science Park is capped. [Photo by Li Zhouqin/Nanfang Daily]

The relevant person in charge of Guangdong Medical Valley said that the capped 8-floor building is the innovation incubation center of the park, with a total construction area of over 10,000 square meters. Each floor is constructed to meet the production requirements of GMP workshops and laboratories, and can be customized according to the needs of the project team. More high-tech and high-growth enterprises will be incubated here in the future.


Rendering of the Guangdong Medical Valley·Yundonghai Life Science Park [Photo/fs-hitech.foshan.gov.cn]

The Yundonghai Biological Port, where Guangdong Medical Valley is located, is one of ten innovative and leading characteristic manufacturing parks in Foshan.

As a new park, and in less than a year since the start of construction, Yundonghai Biological Port has introduced 2 projects exceeding 10 billion yuan ($1.47 billion), 1 project exceeding 5 billion yuan, more than 100 reserve projects, and a total intended investment of more than 80 billion yuan.

In addition to introducing physical projects, the port also focuses on introducing a number of public service platforms for the biopharmaceutical industry. At present, the provincial medical device quality inspection center and the Sanshui Hospital of Zhujiang Hospital have been deployed around the park. In the near future, the Foshan Branch of the Evaluation and Certification Center of the Provincial Food and Drug Administration and a series of preclinical animal experiment platforms will also be launched.

The establishment of the platform for the transformation of scientific and technological achievements will further promote the integration of clinical medicine into the whole process of biomedicine and medical device research and development.

The Foshan Hi-tech Zone Management Committee will help Yundonghai focus on high-end medical projects to attract large and well-established companies, and help build it into an internationally renowned and first-class new industrial platform to promote the development of biomedicine in the Guangdong-Hong Kong-Macao Greater Bay Area.